News
Team Trump canceled a $770 mln contract with Moderna to develop an H5 vaccine. In a cost-benefit analysis, it’s a dangerous ...
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results